(Q40016030)

16 September 2017

title

Beta-eudesmol suppresses tumour growth through inhibition of tumour neovascularisation and tumour cell proliferation (English)

1 reference

16 September 2017

1 reference

En-Long Ma

1

1 reference

16 September 2017

Yan-Chun Li

2

1 reference

16 September 2017

Hiroshi Tsuneki

3

1 reference

16 September 2017

Jin-Fang Xiao

4

1 reference

16 September 2017

Ming-Yu Xia

5

1 reference

16 September 2017

Min-Wei Wang

6

1 reference

16 September 2017

Ikuko Kimura

7

1 reference

16 September 2017

publication date

1 January 2008

1 reference

Journal of Asian Natural Products Research

16 September 2017

published in

1 reference

16 September 2017

volume

10

1 reference

16 September 2017

issue

1-2

1 reference

16 September 2017

page(s)

159-167

1 reference

Angiogenesis: regulators and clinical applications

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10286020701394332

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020701394332

Antiangiogenic activity of beta-eudesmol in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020701394332

Beta-eudesmol induces neurite outgrowth in rat pheochromocytoma cells accompanied by an activation of mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020701394332

Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020701394332

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020701394332

Recent advances in angiogenesis, anti-angiogenesis and vascular targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020701394332

Vascular endothelial growth factor is essential for corpus luteum angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020701394332

Vascular endothelial cell growth factor activates CRE-binding protein by signaling through the KDR receptor tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10286020701394332

10.1080/10286020701394332

21 January 2018

Identifiers

DOI

1 reference

16 September 2017

1 reference